[Q62-Q86] ACRP Certified Professional Exam Practice Tests 2026 Pass ACRP-CP with confidence!

QUESTION 62
In preparation for an upcoming site audit, whose responsibility is it to ensure study-related functions were conducted by qualified personnel?

QUESTION 63
Which document confirms the PI’s agreement to permit auditing at the study site?

QUESTION 64
A written description of a trial in which the clinical and statistical description, presentations, and analyses are fully integrated into a single document is called a:

QUESTION 65
When assessing the monitoring needs for a study, sponsors should:

QUESTION 66
Who must be blinded in a double-blind study in order to prevent bias?

QUESTION 67
A study to determine the effective dose and regimen of a new IP for the treatment of hypothyroidism is considered to be:

QUESTION 68
A study subject inadvertently disposed of IP medication bottles. The site should report this to the:

QUESTION 69
Who takes responsibility for initiating a clinical trial?

QUESTION 70
Which of the following documents is maintained by a PI to ensure compliance with sponsor requirements?

QUESTION 71
After the completion or termination of a clinical trial, who should store the enrollment log?

QUESTION 72
A study has been closed for two years after the last approval of a marketing application of an IP. No additional applications are pending and there are no further developments planned for the IP. Which of the following statements is the BEST course of action regarding the destruction of the essential documents?

QUESTION 73
A clinical trial is conducted to measure the effectiveness of music therapy to reduce anxiety in intensive care unit patients. Patients are randomly assigned to receive headphones with music of their choice or headphones with white noise. The group receiving the white noise headphones is considered which type of control group?

QUESTION 74
Which of the following statements accurately describes the responsibilities of stakeholders involved in the conduct of a clinical study?

QUESTION 75
Who is responsible for outlining written procedures in a study to assure that changes or corrections in CRFs are documented, are necessary, and are endorsed by the investigator?

QUESTION 76
Centralized monitoring can:

QUESTION 77
Which of the following should be reviewed and evaluated by qualified experts to assess implications for the safety of the trial subjects?

QUESTION 78
During a mid-study sponsor audit of a clinical trial, the auditor notices that all of the protocol-required subject drug dosing diaries were incomplete. The effect of this will be the inability to:

QUESTION 79
The site submitted all start-up documents for a study to the sponsor and the IRB/IEC. The site also has subjects identified for screening. What should happen FIRST?

QUESTION 80
A study sponsor approaches a facility about participating in their research study. The study sponsor requires use of social media as its sole method of recruitment. The site knows their institutional IRB/IEC does not approve of social media recruiting. How should the site respond?

QUESTION 81
A clinical trial is conducted to test the effect of an investigational drug on cholesterol levels. Statistical analysis will be performed to:

QUESTION 82
Who on the local site research study team is accountable for the unblinding documentation of IP?

QUESTION 83
A root cause analysis should be:

QUESTION 84
A printed, optical, or electronic document designed to record all of the protocol-required information and is transmitted to the sponsor is called a:

QUESTION 85
The IB contains which of the following sections?

QUESTION 86
An impartial witness should be present during the entire informed consent discussion when: